Renaissance Ahead: Why the Best of MedTech Is Yet to Come

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>President - Cardiac & Vascular Research Center of Northen Michigan</li><li>BioStar Capital and Related Investments & BOD - The Biostar Family of Funds (I,II,III,XF, IV )</li><li>Equity/Stock(s)/Options - REVA Medical; Amplitude Vascular Systems; FOLDAX; Versa Vascular; Ablative Systems Inc; V wave (BioSens JNJ)</li></ul>